157 related articles for article (PubMed ID: 14750092)
61. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?
Lenz O; Waheed AA; Baig A; Pop A; Contreras G
Clin J Am Soc Nephrol; 2013 Jan; 8(1):162-71. PubMed ID: 22917704
[TBL] [Abstract][Full Text] [Related]
62. Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.
An Y; Zhou Y; Bi L; Liu B; Wang H; Lin J; Xu D; Wang M; Zhang J; Wang Y; An Y; Zhu P; Xie R; Zhang Z; Mei Y; Liu X; Deng X; Yao Z; Zhang Z; Wang Y; Xiao W; Shen H; Yang X; Xu H; Yu F; Wang G; Lu X; Li Y; Li Y; Zuo X; Li Y; Liu Y; Zhao Y; Guo J; Sun L; Zhao M; Li Z
Clin Rheumatol; 2019 Apr; 38(4):1047-1054. PubMed ID: 30488367
[TBL] [Abstract][Full Text] [Related]
63. Treatment of lupus nephritis: a meta-analysis of clinical trials.
Bansal VK; Beto JA
Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
[TBL] [Abstract][Full Text] [Related]
64. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
[TBL] [Abstract][Full Text] [Related]
65. Effect of long-term normalization of serum complement levels on the course of lupus nephritis.
Laitman RS; Glicklich D; Sablay LB; Grayzel AI; Barland P; Bank N
Am J Med; 1989 Aug; 87(2):132-8. PubMed ID: 2757054
[TBL] [Abstract][Full Text] [Related]
66. Sustained remission of lupus nephritis.
Barber CE; Geldenhuys L; Hanly JG
Lupus; 2006; 15(2):94-101. PubMed ID: 16539280
[TBL] [Abstract][Full Text] [Related]
67. Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
Izmirly PM; Kim MY; Carlucci PM; Preisinger K; Cohen BZ; Deonaraine K; Zaminski D; Dall'Era M; Kalunian K; Fava A; Belmont HM; Wu M; Putterman C; Anolik J; Barnas JL; Diamond B; Davidson A; Wofsy D; Kamen D; James JA; Guthridge JM; Apruzzese W; Rao DA; Weisman MH; ; Petri M; Buyon J; Furie R
Arthritis Res Ther; 2024 Feb; 26(1):54. PubMed ID: 38378664
[TBL] [Abstract][Full Text] [Related]
68. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
69. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
70. Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.
Pereira M; Muscal E; Eldin K; Hicks MJ; Sagcal-Gironella ACP; DeGuzman M; Wenderfer SE
Pediatr Nephrol; 2017 Dec; 32(12):2283-2291. PubMed ID: 28717937
[TBL] [Abstract][Full Text] [Related]
71. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
[TBL] [Abstract][Full Text] [Related]
72. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
Austin HA; Illei GG; Braun MJ; Balow JE
J Am Soc Nephrol; 2009 Apr; 20(4):901-11. PubMed ID: 19297556
[TBL] [Abstract][Full Text] [Related]
73. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
[TBL] [Abstract][Full Text] [Related]
74. Single-dose rituximab in refractory lupus nephritis.
Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
[TBL] [Abstract][Full Text] [Related]
75. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T; Iheozor-Ejiofor Z; Gordon M; Akobeng AK
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD010233. PubMed ID: 31425621
[TBL] [Abstract][Full Text] [Related]
76. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Hu WX; Chen YH; Bao H; Liu ZZ; Wang SF; Zhang HT; Liu ZH
Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933
[TBL] [Abstract][Full Text] [Related]
77. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
78. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
[TBL] [Abstract][Full Text] [Related]
79. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.
Illei GG; Takada K; Parkin D; Austin HA; Crane M; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Pando J; Steinberg AD; Gourley MF; Klippel JH; Balow JE; Boumpas DT
Arthritis Rheum; 2002 Apr; 46(4):995-1002. PubMed ID: 11953977
[TBL] [Abstract][Full Text] [Related]
80. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
